KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $7.9 billion.

  • Quest Diagnostics' Total Non-Current Liabilities fell 529.71% to $7.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 billion, marking a year-over-year decrease of 529.71%. This contributed to the annual value of $8.4 billion for FY2024, which is 2348.62% up from last year.
  • Latest data reveals that Quest Diagnostics reported Total Non-Current Liabilities of $7.9 billion as of Q3 2025, which was down 529.71% from $7.8 billion recorded in Q2 2025.
  • Quest Diagnostics' 5-year Total Non-Current Liabilities high stood at $8.4 billion for Q4 2024, and its period low was $5.9 billion during Q1 2023.
  • In the last 5 years, Quest Diagnostics' Total Non-Current Liabilities had a median value of $6.3 billion in 2021 and averaged $6.8 billion.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first plummeted by 832.97% in 2021, then skyrocketed by 3609.44% in 2024.
  • Quest Diagnostics' Total Non-Current Liabilities (Quarter) stood at $6.3 billion in 2021, then fell by 3.8% to $6.1 billion in 2022, then increased by 11.63% to $6.8 billion in 2023, then grew by 23.49% to $8.4 billion in 2024, then dropped by 5.74% to $7.9 billion in 2025.
  • Its last three reported values are $7.9 billion in Q3 2025, $7.8 billion for Q2 2025, and $7.9 billion during Q1 2025.